drugset / Trial / NCT01095016

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients

NCT01095016

Phase 3 Completed 32 enrolled Taiwan Otsuka Pharm. Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open-label, randomized, cross-over, active-controlled study to evaluate the efficacy and safety effects using Meptin® Swinghaler and Berotec N® Metered Aerosol in stable asthma patients

Timeline

Start
2010-03
Primary completion
2012-09
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenoterol Unknown 200 ug
Subject Salbutamol Unknown 20 ug

Indications